Next Article in Journal
Adsorption Behavior of the L-Theanine onto Cation Exchange Resin ZGSPC106Na and D001SD
Previous Article in Journal
Simultaneous Determination of 11 Mycotoxins in Maize via Multiple-Impurity Adsorption Combined with Liquid Chromatography–Tandem Mass Spectrometry
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tenebrio molitor Proteins-Derived DPP-4 Inhibitory Peptides: Preparation, Identification, and Molecular Binding Mechanism

1
College of Food Science, Southwest University, Chongqing 400715, China
2
Chongqing Key Laboratory of Speciality Food Co-Built by Sichuan and Chongqing, Chongqing 400715, China
3
Chongqing Engineering Research Center for Processing & Storage of Distinct Agricultural Products, Chongqing Technology and Business University, Chongqing 400067, China
4
Westa College, Southwest University, Chongqing 400715, China
5
Dairy Science Department, Faculty of Agriculture, Assiut University, Assiut 71526, Egypt
*
Author to whom correspondence should be addressed.
Foods 2022, 11(22), 3626; https://doi.org/10.3390/foods11223626
Submission received: 21 October 2022 / Revised: 9 November 2022 / Accepted: 11 November 2022 / Published: 13 November 2022

Abstract

:
Inhibition of dipeptidyl peptidase-4 (DPP-4) is an effective way to control blood glucose in diabetic patients. Tenebrio (T.) molitor is an edible insect containing abundant protein. T. molitor protein-derived peptides can suppress the DPP-4 activity. However, the amino acid sequence and binding mechanism of these DPP-4 inhibitory peptides remain unclear. This study used the flavourzyme for T. molitor protein hydrolysis, identified the released peptides with DPP-4 inhibitory effect, and investigated the binding interactions of these peptides with DPP-4. The results showed that flavourzyme efficiently hydrolyzed the T. molitor protein, as demonstrated by the high degree of hydrolysis, disappearance of protein bands in SDS-PAGE, and changes to protein structure. The 4-h flavourzyme hydrolysates showed a good inhibitory effect on DPP-4 (IC50 value of 1.64 mg/mL). The fragment of 1000–3000 Da accounted for 10.39% of the total peptides, but showed the strongest inhibitory effect on DPP-4. The peptides LPDQWDWR and APPDGGFWEWGD were identified from this fraction, and their IC50 values against DPP-4 were 0.15 and 1.03 mg/mL, respectively. Molecular docking showed that these two peptides interacted with the DPP-4 active site via hydrogen bonding, hydrophobic interactions, salt bridge formation, π-cation interactions, and π-π stacking. Our findings indicated that T. molitor protein-derived peptides could be used as natural DPP-4 inhibitors.

Graphical Abstract

1. Introduction

The prevalence of diabetes has been dramatically increasing worldwide in recent years. There are approximately 537 million adults with diabetes worldwide, and 6.7 million deaths among those with diabetes in 2021 (statistics from International Diabetes Federation). In fact, diabetes can lead to many macro- and microvascular complications and affect multiple organs, which seriously threatens human health and causes a huge burden to society [1,2]. Some treatment strategies for diabetes, including oral agents and subcutaneous injections of insulin, are applied to regulate fasting blood glucose in diabetic patients. Among these strategies, the use of dipeptidyl peptidase-4 (DPP-4) inhibitors is receiving wider attention due to its advantage of low risk of hypoglycemia [3,4]. After food intake, insulin secretion from pancreatic islets is induced by the glucose inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) [5,6], but these incretins can be inactivated by the metabolic enzyme DPP-4. Thus, inhibiting DPP-4 extends the half-life of active incretins, thereby contributing to glycemic regulation. Currently, there are some synthetic DPP-4 inhibitors available, but they may have side effects, including joint pain, inflammation of the pancreas, and allergic reactions. Thus, some natural functional components, such as protein peptides, resveratrol, and flavones have been screened for their inhibitory activity against DPP-4 [7,8]. Food proteins-derived bioactive peptides usually consisting of 2–20 amino acid residues have been reported to possess various health-promoting attributes, such as anti-hypertensive, anti-diabetic, cholesterol-lowering, immunoregulatory, anti-oxidant, and mineral absorption-promoting effects [9,10,11,12]. The peptides with inhibitory activity against DPP-4 have received increasing attention due to their higher potency, selectivity, and safety [11,13]. For example, the peptide QLRDIVDK from Sorghum bicolor protein has a strong affinity to DPP-4, thereby showing a potent inhibition of DPP-4 [8]. Chinese black tea-derived peptide AGFAGDDAPR inhibits DPP-4 activity, contributing to the improvement of pancreatic function in diabetic mice [14].
Edible insects, such as Tenebrio (T.) molitor, Bombyx mori, Locusta migratoria, and Blaptica dubia, are abundant in protein. The insect protein is considered an alternative protein source because of its low environmental effect [15]. Moreover, insect protein is an excellent source of bioactive peptides. It has been reported that insect protein-derived peptides possess various bioactivities, such as anti-oxidant, anti-hypertensive, anti-cancer, anti-inflammatory, anti-diabetic, and anti-microbial activities [16]. T. molitor is an edible, highly nutritious insect due to its high content of fats, proteins, vitamins, and minerals, which is consumed in many countries and has been processed into various insect-based food products, e.g., frankfurters [17,18]. The enzymatic hydrolysates of T. molitor protein have been shown to have antithrombotic activity, inhibit α-glucosidase, protect AML12 cells from oxidative damage, and decrease the blood pressure of hypertensive rats [19,20,21,22]. Moreover, compared with unhydrolyzed T. molitor proteins, the cuticular protein hydrolysates exhibit higher inhibitory activity against DPP-4 [23]. Although researchers speculate that the peptide APVAH from T. molitor protein is a DPP-4-inhibitory peptide [24], to date, the amino acid sequence of T. molitor protein-derived peptides with an inhibitory effect on DPP-4 activity remains unclear. This study determined the inhibitory activity of T. molitor protein hydrolysates against DPP-4, and then identified the DPP-4 inhibitory peptides by LC-MS/MS and solid-phase synthesis. Furthermore, the interaction types between peptides and DPP-4 active site were investigated by molecular docking. This is the first study to identify the T. molitor protein-derived peptides with DPP-4 inhibition and characterize their binding mechanisms with DPP-4.

2. Materials and Methods

2.1. Materials

Fresh T. molitor were donated by Prof. Ning Li at Chongqing Technology and Business University, while 8-anilino-1-naphthalenesulfonic acid (ANS), trypsin (250 N.F.U/mg), flavourzyme (≥30,000 U/g), papain (≥800,000 U/g), and alcalase (≥200,000 U/g) were bought from Beijing Solarbio Science and Technology Co., Ltd. (Beijing, China). The o-phthaldialdehyde (OPA) was bought from Shanghai Bide Medical Technology Co., Ltd. (Shanghai, China). The acetonitrile, trifluoroacetic acid, and formic acid were chromatographic grade and were supplied by Chengdu Kelong Chemical Co., Ltd. (Chengdu, China). DPP-4 (≥4000 units/μg) and its substrate Gly-Pro-p-nitroanilide were bought from Millipore Sigma (Burlington, MA, USA).

2.2. The Enzymatic Hydrolysis of T. molitor Protein

The T. molitor protein was isolated according to a reported method [25]. Briefly, lyophilized and defatted T. molitor were crushed, and dissolved with deionized water (1/20, w/v). After regulating the pH value to 9.5 by 1 M NaOH solution and stirring for 1 h, the solution was centrifuged to collect the supernatant (4 °C, 3000 g, 15 min). The supernatant was regulated to pH 4.5, and further centrifuged to collect the pellet, which was then freeze-dried.
In this study, the proteases alcalase, flavourzyme, papain, trypsin were used for the hydrolysis of T. molitor proteins. Briefly, the lyophilized protein (5%, w/v) was resuspended in deionized water, and then the temperature and pH value of the solution were regulated to the optimal temperature and pH values for the corresponding enzyme (alcalase, 50 °C, pH 11.0; flavourzyme, 50 °C, pH 7.0; papain, 55 °C, pH 6.0; trypsin, 37 °C, pH 8.0). Afterward, the corresponding enzyme was added at a ratio of 5% (w/w), maintaining constant temperature and pH during hydrolysis process. The reaction solution was sampled at different hydrolysis times (0, 30, 60, 120, 180, 240, and 300 min), and ultimately heated at 85 °C for 20 min. The supernatant of the reaction solution was adjusted to neutral pH, and lyophilized for subsequent use.

2.3. Degree of Hydrolysis (DH) Assay

The OPA method was adopted for the assay of the DH. In brief, the OPA working solution was prepared according to a previous publication [26]. The 3 mL of OPA working solution was mixed with 400 μL of serine standard (0.1 mg/mL), sample solution (1 mg/mL), and deionized water, respectively. After 2 min, the optical density at 340 nm was recorded. The DH was calculated according to a previously described equation [26]. In addition, the reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed to evaluate the hydrolysis of T. molitor proteins. Briefly, each sample was mixed with a 5 × loading buffer (Beyotime, Shanghai, China), and boiled for 5 min. Then, 10 μL of each sample was loaded on the gel (Beyotime), and after protein separation by SDS-PAGE, the gel was stained with Coomassie Blue (Beyotime).

2.4. Analysis of DPP-4 Inhibition Activity

The inhibition of each sample on DPP-4 was assayed according to a previously described method [27]. Briefly, 20 μL of each sample solution, 50 μL of Tris-HCl buffer (pH8.0, 100 mM), and 100 μL of substrate were mixed in a well of a 96-well plate, then incubated at 37 °C for 10 min. Afterward, the 30 μL of DPP-IV solution was added, then placed at 37 °C for 40 min incubation. Afterward, the optical density was recorded at 405 nm using a BioTek Synergy H1 microplate reader (BioTek, Winooski, VT, USA). The inhibitory effect of the samples on DPP-4 was calculated according to a previously described equation [27].

2.5. Structural Characterization

2.5.1. Ultraviolet (UV) Absorption Spectroscopy

The T. molitor protein hydrolysates (0.01%, w/v) were added to deionized water and resuspended well. The UV spectra of the hydrolysates were recorded using a Nanovue Plus UV-visible spectrophotometer (GE Healthcare Life Science, Piscataway, NJ, USA) in the range of 190–800 nm.

2.5.2. Relative Fluorescence Intensity

A 1.5 mL aliquot of T. molitor protein hydrolysate solution (1 μg/mL, in 10 mM PBS at pH 7.0) was mixed with 20 μL of an 8 mM ANS solution. Relative fluorescence intensity was assayed using an F-2500 fluorescence spectrometer (Hitachi Ltd., Tokyo, Japan) in the range of 400–700 nm [28].

2.5.3. Circular Dichroism (CD) Spectroscopy

After resuspending the T. molitor protein hydrolysate (0.01%, w/v) in deionized water, the secondary structure of the protein peptides was analyzed by a MOS-500 CD spectrometer (Bio-Logic, Seyssinet-Pariset, France) in the range of 190–250 nm. The scan speed was 100 nm/min, and the path length was 1 mm. The ellipticity (θ) was measured in millidegrees (mdeg).

2.5.4. Molecular Weight Distribution

A TSK® gel G2000 SWXL (7.8 mm × 300 mm) column (Tosoh, Tokyo, Japan) was used for separation. The mobile phase consisted of acetonitrile, water, and trifluoroacetic acid (40/60/0.05, v/v/v). The flow rate was 0.5 mL/min, and monitoring wavelength was 214 nm [29].

2.6. Peptide Identification

The peptides of the T. molitor protein hydrolysates were analyzed by LC-MS/MS [30]. Briefly, the peptides were separated on a U-3000 ultra-high performance liquid chromatography system (Thermo Fisher Scientific Inc., Waltham, MA, USA) coupled with an Orbitrap Fusion™ Tribrid™ mass spectrometer (Thermo Fisher Scientific Inc.), equipped with a C18 (4.6 mm × 250 mm, 5 μm, 300 Å) column (Grace Vydac, Hesperia, CA, USA). The mobile phases used for peptide separation consisted of 0.1% formic acid (FA) in acetonitrile and 0.1% FA in water. The recorded MS/MS spectra were searched in the UniProt database using the SEQUEST Proteome Discoverer 1.4 package (Thermo Fisher Scientific Inc.). PeptideRanker (http://distilldeep.ucd.ie/PeptideRanker/) (accessed on 21 October 2022) and ToxinPred (https://webs.iiitd.edu.in/raghava/toxinpred/design.php) (accessed on 21 October 2022) were used to predict the possible bioactivity and toxicity of the peptides.

2.7. The Synthesis of Peptide

The conventional Fmoc solid-phase synthesis method was used to prepare peptides with a purity of ≥ 95%, which was performed by Guotai Biotechnology Co. Ltd. (Hefei, China).

2.8. Molecular Docking

The three-dimensional (3D) structure of human DPP-4 (2ONC) was downloaded from the Protein Data Bank. The two-dimensional (2D) structure of the synthesized peptide was drawn using ChemDraw 19.0 (PerkinElmer, Waltham, MA, USA), and then converted to 3D structure and subjected to energy minimization with the Chem3D 19.0 software (PerkinElmer, Waltham, MA, USA). The University of California, San Francisco (UCSF) DOCK 6.9 (https://dock.compbio.ucsf.edu/) (accessed on 21 October 2022) was used to predict the binding between the synthesized peptides and the DPP-4 enzyme. The flexible ligand docking was executed and the grid score (kcal/mol) was calculated for each output pose.

2.9. Statistical Analysis

The data is shown as the mean ± standard deviation. The one-way analysis of variance (ANOVA) and Tukey′s post hoc test were used for the statistical analysis (p < 0.05, significant differences).

3. Results

3.1. DH of the T. molitor Protein Hydrolysates

The results shown in Figure 1A reveal that the DH of all the hydrolysates generated by trypsin, alcalase, and papain was less than 6.5%, while that generated by flavourzyme hydrolysates was higher. The DH of the flavourzyme hydrolysates was increased with the reaction time, and the 4-h hydrolysates had the highest DH (23.25 ± 1.03%). The SDS-PAGE analysis indicated that the major bands of T. molitor protein hydrolysates distributed from 10 to 100 kDa, and flavourzyme treatment effectively hydrolyzed T. molitor protein above 15 kDa (Figure 1B).
Taken together, the flavourzyme hydrolysates had the highest DH in comparison to the hydrolysates generated from other proteases, indicating that the flavourzyme hydrolysis contributed to the release of short-chain peptides from T. molitor protein. Generally, the short-chain peptides have great potential in exerting biological activities. Thus, the flavourzyme was selected for subsequent T. molitor protein hydrolysis.

3.2. Inhibition Effect of the T. molitor Protein Hydrolysates on DPP-4

The results presented in Figure 1C show that the inhibitory activity of all flavourzyme hydrolysates against DPP-4 was higher compared with T. molitor protein (p < 0.05). Although the DPP-4 inhibitory effect of these hydrolysates increased little with the hydrolysis time, the 4 h enzymatic treatment reached the greatest inhibitory activity against DPP-4 (57.56 ± 2.59%) and thus was used for subsequent analysis. Furthermore, the 4-h flavourzyme hydrolysates showed a dose-dependent inhibitory effect on DPP-4 activity (Figure 1D), and its inhibitory activity against DPP-4 reached up to 86.59 ± 3.21% (final concentration of hydrolysates, 4 mg/mL).

3.3. Structural Characteristics of the T. molitor Protein Hydrolysates

In comparison to the control sample (unhydrolyzed T. molitor protein), the UV absorption of flavourzyme hydrolysates is markedly increased, indicating that flavourzyme treatment led to conformational changes of the proteins and thereby the exposure of aromatic amino acids (Figure 2A). As we anticipated, the relative fluorescence intensity of the T. molitor protein hydrolysates after ANS binding was higher than that of unhydrolyzed T. molitor protein, demonstrating that the flavourzyme hydrolysis led to the exposure of hydrophobic residues (such as aromatic amino acids) of T. molitor proteins (Figure 2B). In addition, Figure 2C showed that the CD spectrum of unhydrolyzed T. molitor proteins had a major negative trough at around 220 nm, indicating their α-helical structure, whereas this typical α-helix disappeared in the flavourzyme hydrolysates. Moreover, the analysis of the molecular weight distribution of 4-h flavourzyme hydrolysates reveals that the fraction lower than 1000 Da accounted for 67.08% of the total hydrolysate, while the fractions with 1000–3000 Da and >3000 Da accounted for 10.39% and 22.54%, respectively (Figure 2D).

3.4. Identification of Peptides of the T. molitor Protein Hydrolysates

In order to identify the peptide from the T. molitor protein hydrolysates, we divided the hydrolysates into three fractions according to molecular weight. The results presented in Figure 3 show that, among three fractions, the fraction with 1000 to 3000 Da exhibited the highest inhibition effect on DPP-4, and had higher inhibitory activity against DPP-4 than the 4-h flavourzyme hydrolysates (p < 0.05). Therefore, the fraction of 1000–3000 Da was subjected to further analysis for peptide identification. As shown in Table 1, thirteen non-toxic peptides with a PeptideRanker score > 0.60 were identified. It was worth noticing that the PeptideRanker score of peptides APPDGGFWEWGD, LPDQWDWR, NEAYFGFPR, SNGLPFPTRP, and GLQFPTRPNF was higher than 0.80. These peptides were derived from Beta-1, 3-glucanase, C1 family cathepsin L11, Hexamerin 1, Hexamerin 1, and 86 kDa early-staged encapsulation-inducing protein, respectively (Table 1).

3.5. The Inhibition of the Synthesized Peptides on DPP-4

The peptides APPDGGFWEWGD, LPDQWDWR, NEAYFGFPR, SNGLPFPTRP, and GLQFPTRPNF were synthesized and their activity was evaluated in this study. Among these five peptides, peptide LPDQWDWR showed the highest DPP-4 inhibitory effect, and its inhibitory activity against DPP-4 was markedly higher than that of the flavourzyme hydrolysates and 1000–3000 Da fractions (p < 0.05) (Figure 4A). Peptide APPDGGFWEWGD also showed good DPP-4 inhibition, which was not significantly different than that of the 1000–3000 Da fractions (p > 0.05). The IC50 values of peptides LPDQWDWR and APPDGGFWEWGD against DPP-4 activity were 0.15 and 1.03 mg/mL, respectively (Figure 4B,C). In contrast, peptides NEAYFGFPR, SNGLPFPTRP, and GLQFPTRPNF exhibited weak inhibitory activity against DPP-4 compared to peptides LPDQWDWR and APPDGGFWEWGD (Figure 4A).

3.6. Interaction between the Synthesized Peptides and DPP-4 Active Site

The results presented in Figure 5A and Table 2 show that peptide LPDQWDWR interacted with the Arg125, Asp556, Lys554, Tyr662, Gln553, Tyr547, Val711, Val656, Tyr666, Trp659, Phe357, Tyr631, and Trp629 residues of DPP-4 by hydrophobic interactions, π-cation interactions, π-π stacking, salt bridge formation, and hydrogen bonding. Peptide APPDGGFWEWGD interacted with the Arg125, Arg356, Arg358, Lys554, Tyr662, Leu561, Ser630, Val711, Val656, Tyr666, Phe357, Tyr631, and Trp629 residues of DPP-4 by the above-mentioned interaction types except for π-cation interactions (Figure 5B and Table 2). In addition, as shown in Figure 5C, the grid score of peptide LPDQWDWR against DPP-4 was −324.33 kcal/mol, which was lower than the grid score of peptide APPDGGFWEWGD against DPP-4 (−156.43 kcal/mol).

4. Discussion

GLP-1 and GIP are two crucial incretins, which have mainly contributed to the insulin response after meal intake [31]. Suppressing the activity of DPP-4 can increase the level of active incretins, thereby decreasing blood glucose in diabetic patients [32]. Based on the consideration of the adverse effects caused by the chemically synthesized inhibitors, some peptides with inhibitory effects on DPP-4 activity obtained from natural proteins, including milk, egg, grain, edible insects, and aquatic proteins have been widely reported [33,34]. In the current study, the flavourzyme effectively hydrolyzed T. molitor proteins, as indicated by the results of the DH, SDS-PAGE analysis, and structural characteristics of flavourzyme hydrolysates. We noticed that the hydrolysis of T. molitor protein by flavourzyme was markedly higher than that by the other three enzymes, which was associated with the type of proteases. Alcalase and trypsin are serine endoproteases, and papain belongs to cysteine endoprotease. By contrast, flavourzyme is a mixture including aminopeptidase, carboxypeptidase, and endoprotease [35], indicating that flavourzyme can guarantee extensive hydrolysis of T. molitor protein (the maximum DH, 23.25 ± 1.03%). Similarly, Purschke et al. reported that flavourzyme can effectively hydrolyze Locusta migratoria protein, and the DH of the 4-h flavourzyme hydrolysates reaches 16.4 ± 0.4% [36]. The DH of Acheta domesticus protein hydrolysates generated by 2 h of flavourzyme hydrolysis exceeds 30% [37]. These results indicate that flavourzyme is suitable to be used for the hydrolysis of edible insect proteins. Moreover, the hydrolysates obtained by the 4-h hydrolysis with flavourzyme dose-dependently inhibited the DPP-4 enzyme. The IC50 value of the 4-h flavourzyme hydrolysates against DPP-4 activity was 1.64 mg/mL. Consistent with our study, other researchers have reported that the IC50 value of T. molitor protein hydrolysates against DPP-4 activity ranges from 0.83 to 2.62 mg/mL [23,24]. The IC50 value of T. molitor protein hydrolysates against DPP-4 activity in these studies is different, likely due to the differences of the enzyme types and hydrolysis conditions used.
It has been reported that the length and size of peptides influence their inhibitory activity against DPP-4. Rivero-Pino et al. obtained and evaluated six fractions with different molecular weight distribution from T. molitor protein hydrolysates, and found that the fractions of 500–1600 Da and 1600–3000 Da had a smaller IC50 value against DPP-4 in comparison to the original hydrolysates and other fractions [24]. Other researchers also reported that the salmon skin collagen and Antarctic krill-derived peptides below 3000 Da showed a higher inhibitory effect on DPP-4 than other fractions [38,39]. Similar to these results, our study demonstrated that the fraction with 1000–3000 Da had higher DPP-4 inhibition compared with the T. molitor protein hydrolysates and other fractions, which indicated that the fraction with 1000–3000 Da has structural features recognized by DPP-4 and thus acts as a substrate for DPP-4. Additionally, the amino acid composition and sequence affect the inhibitory effect of peptides on DPP-4. The occurrence of hydrophobic amino acids in peptides contribute to the binding between peptides and DPP-4 active site, which is crucial to the DPP-4 inhibitory effect of peptides [13,40]. In this study, two novel peptides LPDQWDWR and APPDGGFWEWGD contained 50% hydrophobic residues, and showed excellent inhibitory effects on DPP-4. The DPP-4 inhibitory peptides LPPEHDWR and LPAVTIR identified from Bombyx mori protein also contain 50% and 71.43% hydrophobic residues, respectively, and the peptide LPAVTIR with more hydrophobic residues shows more potent inhibition on DPP-4 [34]. Furthermore, the DPP-4 inhibitory peptides with four or more amino acids frequently have leucine/glycine/isoleucine, proline/leucine/lysine, alanine/valine/glycine/proline at positions one, two, and three from their amino terminals, and proline/leucine/arginine at their carboxyl terminals [6]. Among the five synthesized peptides in this study, peptide LPDQWDWR had the typical characteristics of DPP-4 inhibiting peptides, including the leucine and proline at positions 1 and 2 from the amino terminal, and the arginine at the carboxyl-terminal. Similarly, the Bombyx mori protein-derived DPP-4 inhibitory peptide LPAVTIR has the leucine, proline, and alanine at positions 1, 2, and 3 from the amino-terminal, and the arginine at the carboxyl-terminal [34], and its IC50 value of 0.148 mg/mL against DPP-4 is almost same as the peptide LPDQWDWR identified by our research [34].
The inhibition of peptides against DPP-4 may be dependent on their bindings to the DPP-4 active site. Hydrogen bond and hydrophobic interactions are considered to be critical interaction types [41]. Some peptides derived from food proteins (such as sheep whey and sturgeon skin) can dock into the DPP-4 active site via hydrophobic interactions and hydrogen bonding [42,43]. The Tyr662, His740, Glu205, Ser630, Arg125, Tyr631, Glu206, Tyr547, Phe357, and Tyr666 are important residues of the DPP-4 active site [44]. Our findings showed that peptide LPDQWDWR interacted with the Arg125 residue of the DPP-4 active site by salt bridge formation, π-cation interactions, and hydrogen bonding, and it interacted with the Tyr662, Tyr631, Phe357, and Tyr547 residues by π-π stacking, hydrophobic interactions, hydrophobic interactions, and hydrogen bonding, respectively. Peptide APPDGGFWEWGD interacted with the Arg125, Tyr662, and Ser630 residues of the DPP-4 active site by salt bridge formation, π-π stacking, and hydrogen bonding, respectively, and interacted with the Phe357, Tyr666, and Tyr631 residues by hydrophobic interactions. Taken together, the interaction types and the number of hydrogen bonds of peptide LPDQWDWR with DPP-4 active site were more numerous than those of peptide APPDGGFWEWGD. In addition, peptide LPDQWDWR had a more negative grid score than peptide APPDGGFWEWGD, indicating that peptide LPDQWDWR may form a more stable binding with DPP-4 compared to peptide APPDGGFWEWGD. Thus, peptide LPDQWDWR had a stronger inhibitory activity against DPP-4 than peptide APPDGGFWEWGD.

5. Conclusions

Our results demonstrated that the T. molitor protein hydrolysates generated by flavourzyme possessed good DPP-4 inhibitory effects. Two novel peptides (LPDQWDWR and APPDGGFWEWGD) identified from the flavourzyme hydrolysates interacted with the DPP-4 active site, thereby potently inhibiting the DPP-4 activity. This study provided evidence for T. molitor protein-derived peptides as natural DPP-4 inhibitors, and contributed to the development of T. molitor-related functional foods.

Author Contributions

Conceptualization, J.Y.; methodology, J.Y. and X.Z. (Xilu Zhang); software, J.Y. and A.M.H.; validation, J.S.; investigation, J.T.; resources, H.S., Y.Z., and N.L.; data curation, J.T. and X.Z. (Xinyi Zhou); writing—original draft preparation, J.S.; writing—review and editing, J.S.; visualization, J.Y.; supervision, J.S.; project administration, J.S.; funding acquisition, J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Natural Science Foundation of Chongqing (cstc2021jcyj-msxmX0772), the National Training Program of Innovation and Entrepreneurship for Undergraduates (202210635116), the Fundamental Research Funds for the Central Universities (SWU019026), the Science and Technology Research Program of Chongqing Municipal Education Commission (KJQN201900822), the Chongqing Engineering Research Center for Processing and Storage of Distinct Agricultural Products (KFJJ2019090), and the Chongqing Technology and Business University (1956024).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Makrilakis, K. The role of DPP-4 inhibitors in the treatment algorithm of type 2 diabetes mellitus: When to select, what to expect. Int. J. Environ. Res. Public Health 2019, 16, 2720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Prahalad, P.; Tanenbaum, M.; Hood, K.; Maahs, D. Diabetes technology: Improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabet. Med. 2018, 35, 419–429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Gomha, S.M.; Eldebss, T.M.; Badrey, M.G.; Abdulla, M.M.; Mayhoub, A.S. Novel 4-heteroaryl-antipyrines as DPP-IV inhibitors. Chem. Biol. Drug Des. 2015, 86, 1292–1303. [Google Scholar] [CrossRef] [PubMed]
  4. Abbas, G.; Al Harrasi, A.; Hussain, H.; Hamaed, A.; Supuran, C.T. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2). Bioorg. Chem. 2019, 86, 305–315. [Google Scholar] [CrossRef] [PubMed]
  5. Casanova-Martí, À.; Bravo, F.I.; Serrano, J.; Ardévol, A.; Pinent, M.; Muguerza, B. Antihyperglycemic effect of a chicken feet hydrolysate via the incretin system: DPP-IV-inhibitory activity and GLP-1 release stimulation. Food Funct. 2019, 10, 4062–4070. [Google Scholar] [CrossRef]
  6. Nongonierma, A.B.; Fitzgerald, R.J. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins. J. Food Biochem. 2019, 43, e12451. [Google Scholar] [CrossRef] [Green Version]
  7. Singla, R.K.; Kumar, R.; Khan, S.; Kumari, K.; Garg, A. Natural products: Potential source of DPP-IV inhibitors. Curr. Protein Pept. Sci. 2019, 20, 1218–1225. [Google Scholar] [CrossRef]
  8. Majid, A.; Lakshmikanth, M.; Lokanath, N.; Priyadarshini, C.P. Generation, characterization and molecular binding mechanism of novel dipeptidyl peptidase-4 inhibitory peptides from sorghum bicolor seed protein. Food Chem. 2022, 369, 130888. [Google Scholar] [CrossRef]
  9. Chalamaiah, M.; Ulug, S.K.; Hong, H.; Wu, J. Regulatory requirements of bioactive peptides (protein hydrolysates) from food proteins. J. Funct. Foods 2019, 58, 123–129. [Google Scholar] [CrossRef]
  10. Li, T.; Zhang, X.; Ren, Y.; Zeng, Y.; Huang, Q.; Wang, C. Antihypertensive effect of soybean bioactive peptides: A review. Curr. Opin. Pharm. 2022, 62, 74–81. [Google Scholar] [CrossRef]
  11. Acquah, C.; Dzuvor, C.K.; Tosh, S.; Agyei, D. Anti-diabetic effects of bioactive peptides: Recent advances and clinical implications. Crit. Rev. Food Sci. Nutr. 2022, 62, 2158–2171. [Google Scholar] [CrossRef] [PubMed]
  12. Akbarian, M.; Khani, A.; Eghbalpour, S.; Uversky, V.N. Bioactive peptides: Synthesis, sources, applications, and proposed mechanisms of action. Int. J. Mol. Sci. 2022, 23, 1445. [Google Scholar] [CrossRef]
  13. Pei, J.; Liu, Z.; Pan, D.; Zhao, Y.; Dang, Y.; Gao, X. Transport, stability, and in vivo hypoglycemic effect of a broccoli-derived DPP-IV inhibitory peptide VPLVM. J. Agric. Food Chem. 2022, 70, 4934–4941. [Google Scholar] [CrossRef] [PubMed]
  14. Lu, Y.; Lu, P.; Wang, Y.; Fang, X.; Wu, J.; Wang, X. A novel dipeptidyl peptidase IV inhibitory tea peptide improves pancreatic β-cell function and reduces α-cell proliferation in streptozotocin-induced diabetic mice. Int. J. Mol. Sci. 2019, 20, 322. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Villaseñor, V.M.; Enriquez-Vara, J.N.; Urías-Silva, J.E.; Mojica, L. Edible insects: Techno-functional properties food and feed applications and biological potential. Food Rev. Int. 2021, 1–27. [Google Scholar] [CrossRef]
  16. Lee, J.H.; Kim, T.-K.; Jeong, C.H.; Yong, H.I.; Cha, J.Y.; Kim, B.-K.; Choi, Y.-S. Biological activity and processing technologies of edible insects: A review. Food Sci. Biotechnol. 2021, 30, 1003–1023. [Google Scholar] [CrossRef]
  17. Jeon, Y.-H.; Son, Y.-J.; Kim, S.-H.; Yun, E.-Y.; Kang, H.-J.; Hwang, I.-K. Physicochemical properties and oxidative stabilities of mealworm (Tenebrio molitor) oils under different roasting conditions. Food Sci. Biotechnol. 2016, 25, 105–110. [Google Scholar] [CrossRef]
  18. Zhang, F.; Cao, C.; Kong, B.; Sun, F.; Shen, X.; Yao, X.; Liu, Q. Pre-dried mealworm larvae flour could partially replace lean meat in frankfurters: Effect of pre-drying methods and replacement ratios. Meat Sci. 2022, 188, 108802. [Google Scholar] [CrossRef]
  19. Chen, F.; Jiang, H.; Lu, Y.; Chen, W.; Huang, G. Identification and in silico analysis of antithrombotic peptides from the enzymatic hydrolysates of Tenebrio molitor larvae. Eur. Food Res. Technol. 2019, 245, 2687–2695. [Google Scholar] [CrossRef]
  20. Cho, H.-R.; Lee, S.-O. Novel hepatoprotective peptides derived from protein hydrolysates of mealworm (Tenebrio molitor). Food Res. Int. 2020, 133, 109194. [Google Scholar] [CrossRef]
  21. Dai, C.; Ma, H.; Luo, L.; Yin, X. Angiotensin I-converting enzyme (ACE) inhibitory peptide derived from Tenebrio molitor (L.) larva protein hydrolysate. Eur. Food Res. Technol. 2013, 236, 681–689. [Google Scholar] [CrossRef]
  22. Yoon, S.; Wong, N.A.; Chae, M.; Auh, J.-H. Comparative characterization of protein hydrolysates from three edible insects: Mealworm larvae, adult crickets, and silkworm pupae. Foods 2019, 8, 563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Dávalos Terán, I.; Imai, K.; Lacroix, I.M.; Fogliano, V.; Udenigwe, C.C. Bioinformatics of edible yellow mealworm (Tenebrio molitor) proteome reveal the cuticular proteins as promising precursors of dipeptidyl peptidase-IV inhibitors. J. Food Biochem. 2020, 44, e13121. [Google Scholar] [CrossRef] [PubMed]
  24. Rivero-Pino, F.; Guadix, A.; Guadix, E.M. Identification of novel dipeptidyl peptidase IV and α-glucosidase inhibitory peptides from Tenebrio molitor. Food Funct. 2021, 12, 873–880. [Google Scholar] [CrossRef] [PubMed]
  25. Li, Z.; Zhao, S.; Xin, X.; Zhang, B.; Thomas, A.; Charles, A.; Lee, K.S.; Jin, B.R.; Gui, Z. Purification, identification and functional analysis of a novel immunomodulatory peptide from silkworm pupa protein. Int. J. Pept. Res. Ther. 2020, 26, 243–249. [Google Scholar] [CrossRef]
  26. Nielsen, P.; Petersen, D.; Dambmann, C. Improved method for determining food protein degree of hydrolysis. J. Food Sci. 2001, 66, 642–646. [Google Scholar] [CrossRef]
  27. Song, J.; Wang, Q.; Du, M.; Ji, X.; Mao, X. Identification of dipeptidyl peptidase-IV inhibitory peptides from mare whey protein hydrolysates. J. Dairy Sci. 2017, 100, 6885–6894. [Google Scholar] [CrossRef] [Green Version]
  28. Zheng, Z.; Li, J.; Li, J.; Sun, H.; Liu, Y. Physicochemical and antioxidative characteristics of black bean protein hydrolysates obtained from different enzymes. Food Hydrocolloid. 2019, 97, 105222. [Google Scholar] [CrossRef]
  29. Sun, R.; Liu, X.; Yu, Y.; Miao, J.; Leng, K.; Gao, H. Preparation process optimization, structural characterization and in vitro digestion stability analysis of Antarctic krill (Euphausia superba) peptides-zinc chelate. Food Chem. 2021, 340, 128056. [Google Scholar] [CrossRef]
  30. Zhang, Q.; Tong, X.; Qi, B.; Wang, Z.; Li, Y.; Sui, X.; Jiang, L. Changes in antioxidant activity of Alcalase-hydrolyzed soybean hydrolysate under simulated gastrointestinal digestion and transepithelial transport. J. Funct. Foods 2018, 42, 298–305. [Google Scholar] [CrossRef]
  31. Kothari, S.; Dhami-Shah, H.; Shah, S.R. Antidiabetic drugs and statins in nonalcoholic fatty liver disease. J. Clin. Exp. Hepatol. 2019, 9, 723–730. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Lee, S.; Lee, H.; Kim, Y.; Kim, E. Effect of DPP-IV inhibitors on glycemic variability in patients with T2DM: A systematic review and meta-analysis. Sci. Rep. 2019, 9, 13296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Liu, R.; Cheng, J.; Wu, H. Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: A review. Int. J. Mol. Sci. 2019, 20, 463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Luo, F.; Fu, Y.; Ma, L.; Dai, H.; Wang, H.; Chen, H.; Zhu, H.; Yu, Y.; Hou, Y.; Zhang, Y. Exploration of dipeptidyl Peptidase-IV (DPP-IV) inhibitory peptides from silkworm pupae (Bombyx mori) proteins based on in silico and in vitro assessments. J. Agric. Food Chem. 2022, 70, 3862–3871. [Google Scholar] [CrossRef]
  35. Vogelsang-O’dwyer, M.; Sahin, A.W.; Arendt, E.K.; Zannini, E. Enzymatic hydrolysis of pulse proteins as a tool to improve techno-functional properties. Foods 2022, 11, 1307. [Google Scholar] [CrossRef]
  36. Purschke, B.; Meinlschmidt, P.; Horn, C.; Rieder, O.; Jäger, H. Improvement of techno-functional properties of edible insect protein from migratory locust by enzymatic hydrolysis. Eur. Food Res. Technol. 2018, 244, 999–1013. [Google Scholar] [CrossRef] [Green Version]
  37. Grossmann, K.K.; Merz, M.; Appel, D.; De Araujo, M.M.; Fischer, L. New insights into the flavoring potential of cricket (Acheta domesticus) and mealworm (Tenebrio molitor) protein hydrolysates and their Maillard products. Food Chem. 2021, 364, 130336. [Google Scholar] [CrossRef]
  38. Jin, R.; Teng, X.; Shang, J.; Wang, D.; Liu, N. Identification of novel DPP–IV inhibitory peptides from Atlantic salmon (Salmo salar) skin. Food Res. Int. 2020, 133, 109161. [Google Scholar] [CrossRef]
  39. Lang, M.; Song, Y.; Li, Y.; Xiang, X.; Ni, L.; Miao, J. Purification, identification, and molecular mechanism of DPP-IV inhibitory peptides from defatted Antarctic krill powder. J. Food Biochem. 2021, 45, e13872. [Google Scholar] [CrossRef]
  40. Mudgil, P.; Kilari, B.P.; Kamal, H.; Olalere, O.A.; Fitzgerald, R.J.; Gan, C.-Y.; Maqsood, S. Multifunctional bioactive peptides derived from quinoa protein hydrolysates: Inhibition of α-glucosidase, dipeptidyl peptidase-IV and angiotensin I converting enzymes. J. Cereal Sci. 2020, 96, 103130. [Google Scholar] [CrossRef]
  41. Dai, L.; Kong, L.; Cai, X.; Jiang, P.; Liu, N.; Zhang, D.; Li, Z. Analysis of the structure and activity of dipeptidyl peptidase IV (DPP-IV) inhibitory oligopeptides from sorghum kafirin. J. Agric. Food Chem. 2022, 70, 2010–2017. [Google Scholar] [CrossRef] [PubMed]
  42. Zhang, X.; Wang, R.; Cheng, C.; Zhang, Y.; Ma, Y.; Lu, W. Identification of two novel dipeptidyl peptidase-IV inhibitory peptides from sheep whey protein and inhibition mechanism revealed by molecular docking. Food Biosci. 2022, 48, 101733. [Google Scholar] [CrossRef]
  43. Gui, M.; Gao, L.; Rao, L.; Li, P.; Zhang, Y.; Han, J.W.; Li, J. Bioactive peptides identified from enzymatic hydrolysates of sturgeon skin. J. Sci. Food Agric. 2022, 102, 1948–1957. [Google Scholar] [CrossRef]
  44. Feng, J.; Zhang, Z.; Wallace, M.B.; Stafford, J.A.; Kaldor, S.W.; Kassel, D.B.; Navre, M.; Shi, L.; Skene, R.J.; Asakawa, T. Discovery of alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J. Med. Chem. 2007, 50, 2297–2300. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The degree of hydrolysis (DH) and inhibitory activity against dipeptidyl peptidase-4 (DPP-4) of Tenebrio (T.) molitor protein hydrolysates. (A) DH of T. molitor protein hydrolysates. (B) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of T. molitor protein hydrolysates. (C) Inhibitory effect of T. molitor protein hydrolysates (at a final concentration of 2 mg/mL) on DPP-4 activity. (D) Inhibitory effect of 4-h flavourzyme hydrolysates (at different concentration) on DPP-4. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Figure 1. The degree of hydrolysis (DH) and inhibitory activity against dipeptidyl peptidase-4 (DPP-4) of Tenebrio (T.) molitor protein hydrolysates. (A) DH of T. molitor protein hydrolysates. (B) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of T. molitor protein hydrolysates. (C) Inhibitory effect of T. molitor protein hydrolysates (at a final concentration of 2 mg/mL) on DPP-4 activity. (D) Inhibitory effect of 4-h flavourzyme hydrolysates (at different concentration) on DPP-4. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Foods 11 03626 g001
Figure 2. The structural characterization of Tenebrio molitor protein hydrolysates generated by flavourzyme hydrolysis for 4 h. (A) UV absorption spectroscopy. (B) Relative fluorescence intensity. (C) Circular dichroism spectroscopy. (D) Molecular weight distribution.
Figure 2. The structural characterization of Tenebrio molitor protein hydrolysates generated by flavourzyme hydrolysis for 4 h. (A) UV absorption spectroscopy. (B) Relative fluorescence intensity. (C) Circular dichroism spectroscopy. (D) Molecular weight distribution.
Foods 11 03626 g002
Figure 3. Inhibitory effect of fractions with different molecular weights at a final concentration of 2 mg/mL on DPP-4. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Figure 3. Inhibitory effect of fractions with different molecular weights at a final concentration of 2 mg/mL on DPP-4. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Foods 11 03626 g003
Figure 4. The inhibitory effect of the synthesized peptides on dipeptidyl peptidase-4 (DPP-4) activity. (A) Inhibitory effect of the synthesized peptides at a final concentration of 1 mg/mL on DPP-4 activity. (B) DPP-4 IC50 value of peptide LPDQWDWR against DPP-4 activity. (C) IC50 value of peptide APPDGGFWEWGD against DPP-4 activity. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Figure 4. The inhibitory effect of the synthesized peptides on dipeptidyl peptidase-4 (DPP-4) activity. (A) Inhibitory effect of the synthesized peptides at a final concentration of 1 mg/mL on DPP-4 activity. (B) DPP-4 IC50 value of peptide LPDQWDWR against DPP-4 activity. (C) IC50 value of peptide APPDGGFWEWGD against DPP-4 activity. Data are shown as the mean ± SD (n = 3), and different letters mean significant difference (p < 0.05).
Foods 11 03626 g004
Figure 5. The molecular docking analysis of the synthesized peptides with dipeptidyl peptidase-4 (DPP-4). (A) The predicted binding and interaction of peptide LPDQWDWR with DPP-4. (B) The predicted binding and interaction of peptide APPDGGFWEWGD with DPP-4. (C) The grid score of molecular docking. The yellow dotted line represents salt bridges; the orange dotted line represents π-cation interactions; the green dotted line represents π-π stacking; the blue dotted line represents hydrogen bonding; the grey dotted line represents hydrophobic interactions.
Figure 5. The molecular docking analysis of the synthesized peptides with dipeptidyl peptidase-4 (DPP-4). (A) The predicted binding and interaction of peptide LPDQWDWR with DPP-4. (B) The predicted binding and interaction of peptide APPDGGFWEWGD with DPP-4. (C) The grid score of molecular docking. The yellow dotted line represents salt bridges; the orange dotted line represents π-cation interactions; the green dotted line represents π-π stacking; the blue dotted line represents hydrogen bonding; the grey dotted line represents hydrophobic interactions.
Foods 11 03626 g005
Table 1. The screened peptides identified from Tenebrio molitor protein hydrolysates generated by flavourzyme hydrolysis for 4 h.
Table 1. The screened peptides identified from Tenebrio molitor protein hydrolysates generated by flavourzyme hydrolysis for 4 h.
PeptidesMolecular Weight (kDa)OriginPeptideRankerToxicity
APPDGGFWEWGD1333.54Beta-1, 3-glucanase0.93Non-Toxin
LPDQWDWR1115.32C1 family cathepsin L110.88Non-Toxin
NEAYFGFPR1100.31Hexamerin 10.87Non-Toxin
SNGLPFPTRP1085.36Hexamerin 10.84Non-Toxin
GLQFPTRPNF1176.4886 kDa early-staged encapsulation inducing protein0.81Non-Toxin
FPDDVTNPGGKPW1429.73Beta-1,3-glucanase0.76Non-Toxin
IDDHFLFKEGDRF1638.98Arginine kinase0.70Non-Toxin
GDYDPDAFNNDIGLIKL1880.29Putative serine proteinase0.69Non-Toxin
APVIEKPSPGAF1212.57Acetylcholinesterase0.66Non-Toxin
NGLQFPTRP1029.2986 kDa early-staged encapsulation inducing protein0.66Non-Toxin
IGGGDANAGEFPF1251.50Putative serine proteinase0.64Non-Toxin
YPFWMSGEEFNLK1648.05Hexamerin 20.61Non-Toxin
APDYEEANGKGVIIF1623.01Glutathione S-transferase delta0.60Non-Toxin
Table 2. The interaction types and amino acid residues of the synthesized peptides with dipeptidyl peptidase-4.
Table 2. The interaction types and amino acid residues of the synthesized peptides with dipeptidyl peptidase-4.
PeptidesSalt Bridgesπ-Cation Interactionsπ-π StackingHydrogen BondingHydrophobic Interactions
LPDQWDWRArg125, Asp556, Lys554Arg125Tyr662Arg125, Gln553, Tyr547Val711, Val656, Tyr666, Trp659, Phe357, Tyr631, Trp629
APPDGGFWEWGDArg125, Arg356, Arg358, Lys554/Tyr662Leu561, Ser630Val711, Val656, Tyr666, Arg358, Phe357, Tyr631, Trp629, Lys554
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tan, J.; Yang, J.; Zhou, X.; Hamdy, A.M.; Zhang, X.; Suo, H.; Zhang, Y.; Li, N.; Song, J. Tenebrio molitor Proteins-Derived DPP-4 Inhibitory Peptides: Preparation, Identification, and Molecular Binding Mechanism. Foods 2022, 11, 3626. https://doi.org/10.3390/foods11223626

AMA Style

Tan J, Yang J, Zhou X, Hamdy AM, Zhang X, Suo H, Zhang Y, Li N, Song J. Tenebrio molitor Proteins-Derived DPP-4 Inhibitory Peptides: Preparation, Identification, and Molecular Binding Mechanism. Foods. 2022; 11(22):3626. https://doi.org/10.3390/foods11223626

Chicago/Turabian Style

Tan, Jiao, Jing Yang, Xinyi Zhou, Ahmed Mahmoud Hamdy, Xilu Zhang, Huayi Suo, Yu Zhang, Ning Li, and Jiajia Song. 2022. "Tenebrio molitor Proteins-Derived DPP-4 Inhibitory Peptides: Preparation, Identification, and Molecular Binding Mechanism" Foods 11, no. 22: 3626. https://doi.org/10.3390/foods11223626

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop